Furthermore, in ischemia-reperfused hearts, ROS impaired cardiac functioning by decreasing NO bioavailability and/or by decreasing endothelial nitric oxide synthase (eNOS) expression/activity [6,7]. Here, NOS3 is linked to ischemia.